On-demand treatment of gastro-oesophageal reflux symptoms: A comparison of ranitidine 75 mg with cimetidine 200 mg or placebo

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 9, 1998, Pages 909-917

  Galmiche, J P ^a,d   Shi, G ^a   Simon, B ^b   Casset Semanaz, F ^c   Slama, A ^c  

^a UNIVERSITÉ DE NANTES   (France)

^b Kreiskrankenhaus Schwetzingen   (Germany)

^c Laboratoire Glaxo Wellcome   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; PLACEBO; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS;

ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; CIMETIDINE; DOUBLE-BLIND METHOD; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; RANITIDINE; TREATMENT OUTCOME;

EID: 0031681260     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00384.x     Document Type: Article

References (23)

1. Bruley des Varannes S, Galmiche JP, Bernades P, Bader JP. Douleurs épigastriques et régurgitations: épidémiologie descriptive dans un échantillon représentatif de la population française adulte. Gastroenterol Clin Biol 1988; 12: 721-8.
2. Jones RH, Lydeard SE, Hobbs FD, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401-5.
3. Nebel OT, Fornes MF, Castell DO. Symptomatic gastro-esophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21: 953-6.
4. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
5. Jones RH, Hungin APS, Phillips J, Mills JG. Gastro-oesophageal reflux disease in primary care in Europe. Clinical presentation and endoscopic findings. Eur J Gen Pract 1995; 1: 149-54.
6. Johnsson F, Roth Y, Damgaard Pedersen NE, Joelsson B. Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment Pharmacol Ther 1993; 7: 81-6.
7. Castell DO. Introduction to physiopathology of gastroesophageal reflux. In: Castell DO, Wu WC, Ott DJ, eds. Gastroesophageal Reflux Disease: Pathogenesis, Diagnosis, Therapy. New York: Futura Publishing Company, 1985: 3-9.
8. Beck IT, Connon J, Lemire S. et al. Canadian consensus conference on the treatment of gastroesophageal reflux disease. Can J Gastroenterol 1992; 6: 277-89.
9. Galmiche JP, Janssens J, Mainguet P, Vantrappen G, eds. Le traitement du reflux gastro-oesophagien et de l'oesophagite peptique. In: Reflux gastro-oesophagien et oesophagite peptique. Amsterdam: Excepta Medica, 1994: 117-40.
10. Joelsson B, Johnsson F, Heartburn. The acid test. Gut 1989; 30: 1523-5.
11. Houston LJ, Darekar B, Goodwin C, Mills JG. Ranitidine in the management of symptoms of GORD in primary care. Gastroenterology 1994; 106: A96(Abstract).
12. Sontag S, Robinson M, McCallum RW, Barwick KW, Nardi R. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Arch Intern Med 1987; 147: 1485-91.
13. Simon TJ, Berlin RG, Gardner AH, Stauffer LA, Gould L, Getson AJ. Self-directed treatment of intermittent heartburn: a randomized, multicenter, double-blind, placebo-controlled evaluation of antacid and low doses of an H2-receptor antagonist (famotidine). Am J Ther 1995; 2: 304-13.
14. Koss MA, Hogan DL, Lane J, Steinbach JH, Isenberg JI. Antisecretory effects and pharmacokinetics of low dose ranitidine. Aliment Pharmacol Ther 1993; 7: 417-22.
15. Chambers JB, Pryce D, Bland JM, Northfield TC. Effect of bedtime ranitidine on overnight gastric acid output and intragastric pH: dose/response study and comparison with cimetidine. Gut 1987; 28: 294-9.
16. Wyeth JW, Pounder RE, Snell CC. Decrease of intragastric acidity following low doses of ranitidine. Gastroenterology 1995; 108(Suppl. 4): A261(Abstract).
17. Riemann JF, Hobel W. Cimetidine suspension in patients with stage 0 gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1991; 5: 191-7.
18. Hamilton MR, Sercombe J, Pounder RE, Snell CCL. A comparison of intragastric acidity following low doses of ranitidine and cimetidine. Gut 1996; 39(Suppl. 3): A48-9(Abstract).
19. Fennerty MB, Castell D, Fendrick AM, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment. Suggested disease management guidelines. Arch Intern Med 1996; 156: 477-84.
20. Freston JW, Malagelada JR, Petersen H, McCloy RF. Critical issues in the management of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 1995; 7: 577-86.
21. Shamburek RD, Schubert ML. Control of gastric acid secretion. Histamine H2-receptor antagonist and H+K(+)-ATP axe inhibitors. Gastroenterol Clin North Am 1992; 21: 527-50.
22. Vial T, Goubier C, Bergeret A, Cabrera F, Evreux JC, Descotes J. Side effects of ranitidine. Drug Safety 1991; 6: 94-117.
23. Mills JG, Koch KM, Welster C, Sirgo MA, Fitzgerald K, Wood JR. The safety of ranitidine in over a decade of use. Aliment Pharmacol Ther 1997; 11: 129-37.